Tourmaline Bio, Inc.
TRMLDelisted Oct 28, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827506
Tourmaline Bio, Inc. was delisted on Oct 28, 2025; its insiders filed their last Form 4 on Oct 28, 2025; 134 institutions reported holding it in 13F filings for Q3 2025, worth $1.03B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Tourmaline Bio, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 56 | −2 |
| Shares | 28.9M | 59.5K | 27.3M | −1.53M (−5.3%) |
| Value | $130.4M | $268.0K | $72.1M | −$58.0M (−44.6%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Tourmaline Bio, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Caas Capital Management LP | 297,707 | $783.0K | 0.10% |
| Millennium Management LLC | 53,228 | $140.0K | 0.00% |
| Acadian Asset Management LLC | 40,648 | $106.0K | 0.00% |
| Two Sigma Investments, LP | 35,178 | $93.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 29,668 | $78.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 24,483 | $64.4K | 0.00% |
| Commonwealth Equity Services, LLC | 13,000 | $34.0K | 0.00% |
| Prospera Financial Services Inc | 12,952 | $34.0K | 0.00% |
| Bridgeway Capital Management, LLC | 11,500 | $30.0K | 0.00% |
| SG Americas Securities, LLC | 10,403 | $27.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 391 | $1.00K | 0.00% |
Sold out (13)
Institutions that held Tourmaline Bio, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 266,154 | $1.20M |
| OrbiMed Advisors LLC | 235,995 | $1.06M |
| Sectoral Asset Management Inc | 228,624 | $1.03M |
| Woodline Partners LP | 206,056 | $929.0K |
| Nuveen Asset Management, LLC | 61,523 | $277.0K |
| Ensign Peak Advisors, Inc | 42,833 | $193.0K |
| Tudor Investment Corp Et Al | 42,491 | $192.0K |
| MetLife Investment Management | 13,923 | $62.8K |
| Virtu Financial LLC | 12,399 | $56.0K |
| BIT Capital GmbH | 7,467 | $55.5K |
| Manufacturers Life Insurance Company, The | 10,122 | $45.6K |
| Metropolitan Life Insurance Co | 1,616 | $7.29K |
| UBS Group AG | 825 | $4.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Tourmaline Bio, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Altium Wealth Management LLC | 59,520 | $268.0K |